Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional Acyclovir vs Vitamin D3 for Cutaneous Viral Warts
NCT07448844Phase 4Recruiting
- Sponsor
- Riphah International University
- Start
- Feb 2026
- Primary completion
- Sep 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of aciclovir in cutaneous wart, sponsored by Riphah International University. Started Feb 2026; status: recruiting.
02
Drugs
aciclovir
03
Conditions
cutaneous wart
Beyond the preview
Go deeper on NCT07448844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07448844.